Physician Wealth Advisors Inc. Acquires New Holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC)

Physician Wealth Advisors Inc. bought a new stake in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 264 shares of the financial services provider’s stock, valued at approximately $56,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. CIBC Private Wealth Group LLC boosted its stake in Marsh & McLennan Companies by 0.9% during the 4th quarter. CIBC Private Wealth Group LLC now owns 49,086 shares of the financial services provider’s stock valued at $10,374,000 after purchasing an additional 415 shares in the last quarter. Arrowstreet Capital Limited Partnership acquired a new stake in shares of Marsh & McLennan Companies in the fourth quarter valued at $19,041,000. OneAscent Wealth Management LLC grew its holdings in Marsh & McLennan Companies by 36.8% during the fourth quarter. OneAscent Wealth Management LLC now owns 1,543 shares of the financial services provider’s stock worth $328,000 after acquiring an additional 415 shares during the period. Allstate Corp bought a new stake in Marsh & McLennan Companies in the fourth quarter worth about $3,357,000. Finally, Level Four Advisory Services LLC boosted its position in shares of Marsh & McLennan Companies by 3.2% during the 4th quarter. Level Four Advisory Services LLC now owns 3,497 shares of the financial services provider’s stock valued at $743,000 after purchasing an additional 109 shares in the last quarter. 87.99% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

MMC has been the topic of several research reports. Raymond James reaffirmed an “outperform” rating and issued a $250.00 price target (up previously from $240.00) on shares of Marsh & McLennan Companies in a report on Thursday, February 6th. Keefe, Bruyette & Woods cut their target price on Marsh & McLennan Companies from $214.00 to $210.00 and set an “underperform” rating on the stock in a research report on Monday, February 3rd. Redburn Atlantic initiated coverage on Marsh & McLennan Companies in a research report on Tuesday, March 25th. They issued a “buy” rating and a $281.00 price target for the company. JPMorgan Chase & Co. upped their price objective on shares of Marsh & McLennan Companies from $230.00 to $235.00 and gave the company a “neutral” rating in a research note on Friday, January 3rd. Finally, Royal Bank of Canada raised shares of Marsh & McLennan Companies from a “sector perform” rating to an “outperform” rating and lifted their target price for the stock from $242.00 to $250.00 in a research report on Thursday, December 12th. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $233.41.

Insider Activity at Marsh & McLennan Companies

In related news, CEO Nicholas Mark Studer sold 49,390 shares of the company’s stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $230.16, for a total value of $11,367,602.40. Following the completion of the transaction, the chief executive officer now directly owns 28,329 shares in the company, valued at approximately $6,520,202.64. This represents a 63.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Dean Michael Klisura sold 7,121 shares of the business’s stock in a transaction on Monday, March 10th. The shares were sold at an average price of $234.97, for a total transaction of $1,673,221.37. Following the completion of the sale, the chief executive officer now directly owns 20,935 shares in the company, valued at $4,919,096.95. This trade represents a 25.38 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 57,828 shares of company stock worth $13,350,279 in the last 90 days. 0.30% of the stock is owned by company insiders.

Marsh & McLennan Companies Stock Up 0.6 %

Shares of MMC stock opened at $243.95 on Tuesday. The company has a market capitalization of $119.81 billion, a price-to-earnings ratio of 29.79, a PEG ratio of 2.70 and a beta of 0.95. The company has a debt-to-equity ratio of 1.44, a quick ratio of 1.13 and a current ratio of 1.13. The stock’s 50 day simple moving average is $230.22 and its 200 day simple moving average is $224.18. Marsh & McLennan Companies, Inc. has a twelve month low of $196.17 and a twelve month high of $245.98.

Marsh & McLennan Companies (NYSE:MMC) last posted its quarterly earnings data on Thursday, January 30th. The financial services provider reported $1.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.75 by $0.12. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. As a group, research analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 3rd will be given a dividend of $0.815 per share. The ex-dividend date is Thursday, April 3rd. This represents a $3.26 annualized dividend and a dividend yield of 1.34%. Marsh & McLennan Companies’s dividend payout ratio is presently 39.80%.

Marsh & McLennan Companies Profile

Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.